P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 757-759

  Shnyder, S D ^a,c   Hayes, A J ^a   Pringle, J ^b   Archer, C W ^a  

^a Sch Molec Med Biosci Cardiff U   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Confocal laser scanning microscopy; Drug resistance; Immunohistochemistry; Metallothioneins; Osteosarcoma; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; METALLOTHIONEIN;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOSARCOMA; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR BIOPSY;

EID: 0031658228     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.573     Document Type: Article

References (14)

1. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43
2. Bahnson RR, Banner BF, Ernstoff MS, Lazo JS, Cherian MG, Banerjee D and Chin JL (1991) Immunohistochemical localisation of metallothioneins in transitional cell carcinoma of the bladder. J Urol 146: 1518-1520
3. Chan HSL, Thorner PS, Haddad G and Ling V (1991) Outcome of therapy in osteosarcoma correlates with P-glycoprotein expression. Proc Am Assoc Cancer Res 32: 2173
4. Chin JL, Banerjee D, Kadhim SA, Kontozoglou TE, Chauvin PJ and Cherian MG (1993) Metallothionein in testicular germ cell tumours and drug resistance: clinical correlation. Cancer 72: 3024-3035
5. Juliano RL and Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162
6. Kandel RA, Campbell S, Noble-Topham S, Bell R and Andrulis IL (1995) Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcoma. Diagnost Molec Pathol 4: 59-65
7. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T and Saijo N (1991) Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51: 3237-3242
8. Kondo Y, Kuo SM, Watkins SC and Lazo JS (1995) Metallothionein localisation and cisplatin resistance in human hormone-independent prostatic tumour cell lines. Cancer Res 55: 474-477
9. Richon VM, Schulte N and Eastman A (1987) Multiple mechanisms of resistance to cis-diamminedichlomplatinum (II) in murine leukaemia L1210 cells. Cancer Res 47: 2056-2061
10. Shnyder SD, Pringle J and Archer CW (1944) Expression of P-glycoprotein pre- and post-surgery in osteosarcoma patients receiving pre-operative chemotherapy. Br J Cancer 69 (suppl. 21): 30
11. Thiele DJ, Walling MJ and Hamer DH (1986) Mammalian metallothionein is functional in yeast. Science 231: 854-856
12. Van der Valk P, Van Kalken CK, Ketelaars H and Scheper RJ (1990) Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1: 56-64
13. Weinstein RS, Kusak JR, Kluskens LF and Coon JS (1990) P-glycoproteins in pathology: the multidrug resistance gene family in humans. Human Pathol 21: 34-48
14. Wunder JS, Bell RS, Wold L and Andrulis IL (1993) Expression of the multidrug resistance gene in osteosarcoma: a pilot study. J Orthoped Res 11: 396-403